A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.
This record was last updated December 17, 2024 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evaluate Corneal Endothelial Cell Density in Subjects With Dry Eye Disease Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-21.
Status change: Recruiting → Active, Not Recruiting2024-12-16